Human Coronavirus OC43 as a Low-Risk Model to Study COVID-19
- PMID: 36851792
- PMCID: PMC9965565
- DOI: 10.3390/v15020578
Human Coronavirus OC43 as a Low-Risk Model to Study COVID-19
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has had irreversible and devastating impacts on every aspect of human life. To better prepare for the next similar pandemic, a clear understanding of coronavirus biology is a prerequisite. Nevertheless, the high-risk nature of the causative agent of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), requires the use of a cumbersome biosafety level-3 (BSL-3) confinement facility. To facilitate the development of preventive and therapeutic measures against SARS-CoV-2, one of the endemic strains of low-risk coronaviruses has gained attention as a useful research alternative: human coronavirus OC43 (HCoV-OC43). In this review, its history, classification, and clinical manifestations are first summarized. The characteristics of its viral genomes, genes, and evolution process are then further explained. In addition, the host factors necessary to support the life cycle of HCoV-OC43 and the innate, as well as adaptive, immunological responses to HCoV-OC43 infection are discussed. Finally, the development of in vitro and in vivo systems to study HCoV-OC43 and its application to the discovery of potential antivirals for COVID-19 by using HCoV-OC43 models are also presented. This review should serve as a concise guide for those who wish to use HCoV-OC43 to study coronaviruses in a low-risk research setting.
Keywords: COVID-19; OC43; biosafety level; human coronavirus; low-risk model.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-CoV-2.J Virol Methods. 2022 Jan;299:114317. doi: 10.1016/j.jviromet.2021.114317. Epub 2021 Oct 9. J Virol Methods. 2022. PMID: 34634321 Free PMC article.
-
Evaluation of human coronavirus OC43 and SARS-COV-2 in children with respiratory tract infection during the COVID-19 pandemic.J Med Virol. 2022 Apr;94(4):1450-1456. doi: 10.1002/jmv.27460. Epub 2021 Nov 24. J Med Virol. 2022. PMID: 34786736 Free PMC article.
-
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.Clin Infect Dis. 2022 Aug 24;75(1):e653-e661. doi: 10.1093/cid/ciac057. Clin Infect Dis. 2022. PMID: 35079775 Free PMC article.
-
An overview on the seven pathogenic human coronaviruses.Rev Med Virol. 2022 Mar;32(2):e2282. doi: 10.1002/rmv.2282. Epub 2021 Aug 2. Rev Med Virol. 2022. PMID: 34339073 Review.
-
Roles of Sialyl Glycans in HCoV-OC43, HCoV-HKU1, MERS-CoV and SARS-CoV-2 Infections.Methods Mol Biol. 2022;2556:243-271. doi: 10.1007/978-1-0716-2635-1_17. Methods Mol Biol. 2022. PMID: 36175638 Review.
Cited by
-
Comparative study of the propagation and plaque titration conditions for human coronavirus OC43 as a surrogate for SARS-CoV-2.Arch Virol. 2024 Oct 4;169(10):214. doi: 10.1007/s00705-024-06146-9. Arch Virol. 2024. PMID: 39365483
-
Arctigenin from Forsythia viridissima Fruit Inhibits the Replication of Human Coronavirus.Int J Mol Sci. 2024 Jul 4;25(13):7363. doi: 10.3390/ijms25137363. Int J Mol Sci. 2024. PMID: 39000469 Free PMC article.
-
Comprehensive proteomic analysis of HCoV-OC43 virions and virus-modulated extracellular vesicles.J Virol. 2024 Jul 23;98(7):e0085024. doi: 10.1128/jvi.00850-24. Epub 2024 Jul 2. J Virol. 2024. PMID: 38953378 Free PMC article.
-
Evaluation of Novel Nasal Mucoadhesive Nanoformulations Containing Lipid-Soluble EGCG for Long COVID Treatment.Pharmaceutics. 2024 Jun 11;16(6):791. doi: 10.3390/pharmaceutics16060791. Pharmaceutics. 2024. PMID: 38931912 Free PMC article.
-
Mantis: High-throughput 4D imaging and analysis of the molecular and physical architecture of cells.PNAS Nexus. 2024 Aug 9;3(9):pgae323. doi: 10.1093/pnasnexus/pgae323. eCollection 2024 Sep. PNAS Nexus. 2024. PMID: 39282007 Free PMC article.
References
-
- Gaunt E.R., Hardie A., Claas E.C., Simmonds P., Templeton K.E. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J. Clin. Microbiol. 2010;48:2940–2947. doi: 10.1128/JCM.00636-10. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous